Onspira Therapeutics
Wayne, US · Founded 2017 · Delaware corporation · 1 known investors
Founders & leadership
RL
Roy LevittNamed on SEC filing
ST
Stephen TullmanNamed on SEC filing
PB
Paul BaroneNamed on SEC filing
BL
Brian LortieNamed on SEC filing
DG
Douglas GesslNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 1 round · 2017
▶$1.9MraisedJun 2019 · 30 investors · PharmaceuticalsRule 506(b)
▶$1.9MraisedJun 2019 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Roy LevittExecutive Officer, Director
- Stephen TullmanExecutive Officer, Director
- Paul BaroneExecutive Officer, Director
- Brian LortieExecutive Officer, Director
- Douglas GesslExecutive Officer
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- Minimum investment
- $4K
- Proceeds to insiders
- $30K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Onspira Therapeutics's investors?
- Onspira Therapeutics's investors include BioAdvance.
- How much funding has Onspira Therapeutics raised?
- Onspira Therapeutics has disclosed $1.9M raised across 1 round.
- Where is Onspira Therapeutics headquartered?
- Onspira Therapeutics is headquartered in Wayne, US.